for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Citius Signs Exclusive Option With Novellus To License Novel Stem-Cell Therapy For Acute Respiratory Distress Syndrome (Ards) Associated With Covid-19

April 1 (Reuters) - Citius Pharmaceuticals Inc:

* CITIUS SIGNS EXCLUSIVE OPTION WITH NOVELLUS TO LICENSE NOVEL STEM-CELL THERAPY FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH COVID-19 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up